RE: What happens now12 May 2020 22:44
This is a extract from the Finacial statement last week .
Just read it and let it sink in what it's trying to say , then get yourself a nice glass of your favourite drink have a sip & chuckle to yourself , about the thought where the SP is heading
P
The collaboration agreement, originally scheduled to complete in late April 2020, is being extended by a short period due to the impact on GlobalCo's operations of the novel coronavirus, following which Hemogenyx will either license the antibody to GlobalCo or will in-license GlobalCo's improvements to it on favourable terms.